Business Daily Media


Hong Kong Baptist University-led research unveils cell entry mechanism of SARS-CoV-2 and therapeutic target for COVID-19

HONG KONG SAR - Media OutReach - 20 March 2023 - A study led by scientists from Hong Kong Baptist University (HKBU) has identified a protease called MT1-MMP that is a major host factor behind the infectivity of the SARS-CoV-2 virus in the human body, which leads to the infection of COVID-19 and multi-organ failure.

By applying a humanised antibody called 3A2 that can inhibit the activity of MT1-MMP, the viral load of infected mice was reduced by almost 90%. The research team also demonstrated that the protease is a potential therapeutic target for COVID-19.

Dr Xavier Wong Hoi-leong, Assistant Professor, and Dr Guo Xuanming, researcher of the Teaching and Research Division of the School of Chinese Medicine, introduce the research findings on the cell entry mechanism of SARS-CoV-2 and therapeutic target for COVID-19.
Dr Xavier Wong Hoi-leong, Assistant Professor, and Dr Guo Xuanming, researcher of the Teaching and Research Division of the School of Chinese Medicine, introduce the research findings on the cell entry mechanism of SARS-CoV-2 and therapeutic target for COVID-19.

The research findings have been published in the internationally renowned scientific journal Nature Communications.

ACE2 as a receptor for SARS-CoV-2 cell entry

Vaccination can protect people against COVID-19 and its potential complications, but it is not always effective in individuals with weak immune systems, or against some COVID-19 variants of concern. Thus, the development of a more effective treatment for COVID-19 remains a huge challenge in the post-vaccine era. Understanding the cell entry mechanism of SARS-CoV-2 is vital to curb the spread of the virus, and it will also aid the search for new COVID-19 treatments.

SARS-CoV-2 requires angiotensin-converting enzyme 2 (ACE2), a protein found on the membrane of human cells, as its receptor for cellular entry. Despite the lungs being the major organ affected by SARS-CoV-2 infection, only a small proportion of lung cells express ACE2.

Previous studies found that the infection of organs with low levels of ACE2 expression by SARS-CoV-2 is made possible by a soluble form of ACE2. The soluble ACE2 binds with SARS-CoV-2, carries the virus to cells with low levels of ACE2 expression, and facilitates its entry into the cells.

MT1-MMP mediates cell entry of SARS-CoV-2

A research team led by Dr Xavier Wong Hoi-leong, Assistant Professor of the Teaching and Research Division of the School of Chinese Medicine at HKBU, in collaboration with Dr Yuan Shuofeng, Assistant Professor of the Department of Microbiology at The University of Hong Kong, further studied how the physiological regulation of soluble ACE2 shedding contributes to the aetiology of COVID-19.

The team found that SARS-CoV-2 infection leads to the increased activation of MT1-MMP, a protease crucial for many physiological processes. MT1-MMP mediates the release of soluble ACE2 from ACE2-expressing cells. This soluble ACE2 in turn binds to the spike proteins of SARS-CoV-2 and carries it to the uninfected cells with low levels of ACE2 expression.

Notably, the team demonstrated that the introduction of human-soluble ACE2 enables SARS-CoV-2 to infect the lungs of a laboratory mouse strain (C57BL/6 mice) that is naturally insusceptible to SARS-CoV-2 infection due to the incompatibility of its mouse ACE2 and the viral spike proteins. The findings unveil the mechanism by which the virus hijacks host enzymes to enhance its infectivity, triggering multi-organ infections.

Antibody 3A2 blocks MT1-MMP activity

To study MT1-MMP's functions and how it affects viral infection, the researchers used human cells to create organoids, a 3D tissue structure grown in vitro to resemble and model different organs in the laboratory.

They discovered that blocking MT1-MMP activity with the monoclonal antibody 3A2 effectively depleted soluble ACE2 levels and reduced the degree of infection of SARS-CoV-2 in human lung, heart and liver organoids by 60-80%. Consistent results were obtained using the original strain of SARS-CoV-2, as well as variants of concern, such as Delta and Omicron. The results demonstrate that MT1-MMP is a major host factor that mediates the cell entry of SARS-CoV-2, and that it is also a potential therapeutic target for COVID-19 drugs.

The researchers further tested the effects of applying 3A2 in a mouse COVID-19 model. A group of 11 mice were treated with either 3A2 or vehicle controls. Older mice were used in the experiment as old age is a major risk factor for severe symptoms and mortality for COVID-19. The results show that 3A2 reduced the viral load of SARS-CoV-2 by almost 90% and dramatically alleviated lung tissue damage resulting from infection.

MT1-MMP as a therapeutic target

Dr Wong said: "Two major challenges when it comes to developing COVID-19 drugs are how to enhance treatment results for patients with weakened immune systems, and how to maintain the drugs' effectiveness across different viral strains. 3A2 has good potential to become an effective drug for curing COVID-19 because it antagonises the activity of MT1-MMP, instead of boosting the immunity of patients or acting directly on the virus.

"Our previous studies have demonstrated that 3A2 also offers protection against obesity and diabetes, two major risk factors for severe symptoms and mortality for COVID-19. Therefore, 3A2 could be particularly suitable for high-risk groups, including older adults and people with metabolic disorders. It could also be effective against emerging coronaviruses in the future, because ACE2 is a doorway for many such viruses with similar cell entry mechanisms. Further research and experiments on 3A2 are required before it can be applied in humans."

Hashtag: #HKBU

The issuer is solely responsible for the content of this announcement.

News from Asia

Get Ready for the Summer’s Hottest Sale With iShopChangi

Get the holidays off to a flying start this June as iShopChangi ushers in the summer with irresistible deals to indulge in. Enjoy over 60% off in sitewide discounts, on top of the hottest deals fro...

BKH-ICD Showcases Upcoming New Inland Port to Boost Trade between Thailand and Malaysia

HAT YAI, THAILAND- Media OutReach - 1 June 2023 - BKH-ICD hosted an event in Hatyai with leading shipping lines and major forwarding players from South Thailand to introduce and provide progress u...

Skyborn Renewables appoints Stine Würtz Jepsen as CHRO

HAMBURG, GERMANY - EQS Newswire - 1 June 2023 - Skyborn Renewables (Skyborn) has appointed Stine Würtz Jepsen as Chief Human Resources Officer (CHRO) effective 1 June 2023. ...

Prince Holding Group and CanCham Explore Synergies for Future Partnerships in Cambodia

PHNOM PENH, CAMBODIA - Media OutReach - 1 June 2023 - Prince Holding Group (PHG) recently hosted members of the Canadian Chamber of Commerce in Cambodia (CanCham) for a courtesy visit and di...

Hong Kong In-Home Expo 2023 Opens Today

The largest-ever public access, one-stop home expo HONG KONG SAR - Media OutReach - 1 June 2023 - Organized by Exhibition Group Limited, the largest-ever public access one-stop home expo "Hong Kon...

BingX Launches Special Events for Peer-to-Peer Crypto-Fiat Traders, Providing Rewards for First Trades

SINGAPORE - Media OutReach - 2 June 2023 - BingX, the leading social trading platform, is proud to announce its innovative peer-to-peer (P2P) trading feature, empowering users to ...

New Report Finds Enterprises are Accelerating Edge Adoption to Get Ahead of the Competition with Nearly 70% Leveraging Edge to Solve Critical Business Challenges

NTT’s Edge Advantage report surveyed 600 enterprises leveraging edge to enable data-driven decision making; uncovered concerns around infrastructure capabilities. 88% cite 5G as an importan...

Udokan Copper helps restore Siberian sturgeon population as part of its ESG program

MOSCOW, RUSSIA - Media OutReach - 2 June 2023 - Udokan Copper, one of the largest industrial companies operating in Russia's Far East, is funding a program to restore the population of Siberian st...

Oi Wah and PACM Group entered into MOU

To cooperate in developing mortgage loan businesses including overseas market HONG KONG SAR - Media OutReach - 2 June 2023 - The board of directors of Oi Wah Pawnshop Credit Holdings Limited (HKE...

NetDragon Websoft Inc. Was Invited To Participate In The 18th United Nations Vesak Day and Developed The "UN Vesak Day Metaverse"

BANGKOK, THAILAND - Media OutReach - 2 June 2023 - On 1st and 2nd June, the 18th United Nations Vesak Day was held at the United Nations International Conference Center and Mahachulalongkornrajavi...

Business Reports

Blockchain is a key technology – a computer scientist explains why the post-crypto-crash future is bright

Blockchain technology has many uses beyond cryptocurrency.Yuichiro Chino/Moment via Getty ImagesPeople hear a lot about blockchain technology in relation to cryptocurrencies like bitcoin, which rely on blockchain systems to keep r...

Shippit and Shopline join forces to deliver seamless eCommerce shipping experiences for retailers

Shippit, the industry-leading last-mile delivery platform, is excited to announce a strategic partnership with Shopline, Asia's premier online seller. This partnership embeds Shippit as the delivery solution of choice for reta...

Alistair Wilson returns as Managing Director at Imagination in Melbourne

Award-winning experience design company, Imagination, today announces that Alistair Wilson has been appointed to the newly created role of Managing Director, Melbourne - rejoining the office that he helped establish more than ...